Cargando…

Impact of keratoconus stage on outcome after corneal crosslinking

BACKGROUND: This study aimed to analyze if the outcome after corneal crosslinking (CXL) in progressive keratoconus patients depends on the stage at which the procedure is performed. This knowledge would help to improve success of CXL and to define surgery indications in those patients. METHODS: In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gassel, Caroline Julia, Röck, Daniel, Konrad, Eva-Maria, Blumenstock, Gunnar, Bartz-Schmidt, Karl Ulrich, Röck, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077944/
https://www.ncbi.nlm.nih.gov/pubmed/35524196
http://dx.doi.org/10.1186/s12886-022-02425-8
_version_ 1784702222133624832
author Gassel, Caroline Julia
Röck, Daniel
Konrad, Eva-Maria
Blumenstock, Gunnar
Bartz-Schmidt, Karl Ulrich
Röck, Tobias
author_facet Gassel, Caroline Julia
Röck, Daniel
Konrad, Eva-Maria
Blumenstock, Gunnar
Bartz-Schmidt, Karl Ulrich
Röck, Tobias
author_sort Gassel, Caroline Julia
collection PubMed
description BACKGROUND: This study aimed to analyze if the outcome after corneal crosslinking (CXL) in progressive keratoconus patients depends on the stage at which the procedure is performed. This knowledge would help to improve success of CXL and to define surgery indications in those patients. METHODS: In this retrospective study, 124 consecutive eyes of 100 patients with progressive keratoconus undergoing corneal CXL at the University Eye Hospital Tübingen were included. The eyes were graded according to modified Krumeich stages depending on induced myopia or astigmatism, corneal radii, minimum corneal thickness, and morphological changes. The observation period covered November 2008 to September 2018. Preoperatively, 12 and 24 months after CXL, the best corrected visual acuity (BCVA) was determined and astigmatism as well as tomographic parameters (Kmax, Kmin, central corneal thickness (CCT), minimum corneal thickness (MCT)) were measured by means of a Scheimpflug camera system. RESULTS: BCVA results showed significant differences between the modified Krumeich stages at 12 months (p = 0.014) and at 24 months postoperatively (p = 0.032). Also, astigmatism differed significantly among the stages at 24 months after CXL (p = 0.023). However, no significant differences regarding astigmatism were detectable after 12 months. In terms of Kmax, Kmin, CCT, and MCT, no significant differences between the Krumeich stages were observed. CONCLUSIONS: BCVA showed a significantly higher improvement after CXL in the early stage of keratoconus compared to a higher stage. However, the postinterventional tomographic values did not differ significantly between the different modified Krumeich stages. The significantly higher improvement in BCVA after CXL in the early stage might indicate that earlier intervention provides a higher subjective benefit to the individual. Further studies with larger sample sizes are needed to confirm these findings.
format Online
Article
Text
id pubmed-9077944
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90779442022-05-08 Impact of keratoconus stage on outcome after corneal crosslinking Gassel, Caroline Julia Röck, Daniel Konrad, Eva-Maria Blumenstock, Gunnar Bartz-Schmidt, Karl Ulrich Röck, Tobias BMC Ophthalmol Research BACKGROUND: This study aimed to analyze if the outcome after corneal crosslinking (CXL) in progressive keratoconus patients depends on the stage at which the procedure is performed. This knowledge would help to improve success of CXL and to define surgery indications in those patients. METHODS: In this retrospective study, 124 consecutive eyes of 100 patients with progressive keratoconus undergoing corneal CXL at the University Eye Hospital Tübingen were included. The eyes were graded according to modified Krumeich stages depending on induced myopia or astigmatism, corneal radii, minimum corneal thickness, and morphological changes. The observation period covered November 2008 to September 2018. Preoperatively, 12 and 24 months after CXL, the best corrected visual acuity (BCVA) was determined and astigmatism as well as tomographic parameters (Kmax, Kmin, central corneal thickness (CCT), minimum corneal thickness (MCT)) were measured by means of a Scheimpflug camera system. RESULTS: BCVA results showed significant differences between the modified Krumeich stages at 12 months (p = 0.014) and at 24 months postoperatively (p = 0.032). Also, astigmatism differed significantly among the stages at 24 months after CXL (p = 0.023). However, no significant differences regarding astigmatism were detectable after 12 months. In terms of Kmax, Kmin, CCT, and MCT, no significant differences between the Krumeich stages were observed. CONCLUSIONS: BCVA showed a significantly higher improvement after CXL in the early stage of keratoconus compared to a higher stage. However, the postinterventional tomographic values did not differ significantly between the different modified Krumeich stages. The significantly higher improvement in BCVA after CXL in the early stage might indicate that earlier intervention provides a higher subjective benefit to the individual. Further studies with larger sample sizes are needed to confirm these findings. BioMed Central 2022-05-06 /pmc/articles/PMC9077944/ /pubmed/35524196 http://dx.doi.org/10.1186/s12886-022-02425-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gassel, Caroline Julia
Röck, Daniel
Konrad, Eva-Maria
Blumenstock, Gunnar
Bartz-Schmidt, Karl Ulrich
Röck, Tobias
Impact of keratoconus stage on outcome after corneal crosslinking
title Impact of keratoconus stage on outcome after corneal crosslinking
title_full Impact of keratoconus stage on outcome after corneal crosslinking
title_fullStr Impact of keratoconus stage on outcome after corneal crosslinking
title_full_unstemmed Impact of keratoconus stage on outcome after corneal crosslinking
title_short Impact of keratoconus stage on outcome after corneal crosslinking
title_sort impact of keratoconus stage on outcome after corneal crosslinking
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077944/
https://www.ncbi.nlm.nih.gov/pubmed/35524196
http://dx.doi.org/10.1186/s12886-022-02425-8
work_keys_str_mv AT gasselcarolinejulia impactofkeratoconusstageonoutcomeaftercornealcrosslinking
AT rockdaniel impactofkeratoconusstageonoutcomeaftercornealcrosslinking
AT konradevamaria impactofkeratoconusstageonoutcomeaftercornealcrosslinking
AT blumenstockgunnar impactofkeratoconusstageonoutcomeaftercornealcrosslinking
AT bartzschmidtkarlulrich impactofkeratoconusstageonoutcomeaftercornealcrosslinking
AT rocktobias impactofkeratoconusstageonoutcomeaftercornealcrosslinking